| Literature DB >> 27608636 |
Pantaporn Supakankul1,2,3, Tanavadee Kumchoo1, Supamit Mekchay1.
Abstract
OBJECTIVE: This study was conducted to identify and evaluate the effective single nucleotide polymorphism (SNP) markers for fat deposition in the longissimus dorsi muscles of pigs using the amplified fragment length polymorphism (AFLP) approach.Entities:
Keywords: Amplified Fragment Length Polymorphism (AFLP); Fatty Acid; Intramuscular Fat; Pig
Year: 2016 PMID: 27608636 PMCID: PMC5337912 DOI: 10.5713/ajas.16.0200
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Primer sequences used for genotyping the SNP markers in pigs
| SNP marker | Primer sequence (5′ to 3′) | Size (bp) | Tm (°C) | Restriction enzyme |
|---|---|---|---|---|
| SSC7 g.4937240C>G | F: TGTCTCTCCTCTTGCCCATC | 286 | 58 | |
| SSC8 g.47338181G>A | F: CTGGCATCATCACCCTAAAC | 288 | 60 | |
| SSC9 g.5496647_5496662insdel | F: GCTATGGCTTTCCCTTCTGC | 216/200 | 58 | 16-bp Ins/Del |
| SSC10 g.71225134G>A | F: GCCACCAACCGAGACTACAA | 365 | 58 | |
| SSC17 g.61976696G>T | F: CTTTCTGGGTGTTCCCTCCA | 384 | 58 |
SNP, single nucleotide polymorphism.
Figure 1A representative AFLP profile, of two extremely high and low IMF contents, was obtained with the primer combination E-AGC/T-CCA. The arrow indicates the potential AFLP fragment (AFLP3) for IMF content trait that was recovered from gels and was then analyzed further. Lane M = 100 bp DNA ladder. Lanes 1 to 20 represent DNA samples with high IMF content phenotypes and Lanes 21 to 40 represent DNA samples with low IMF content phenotypes. AFLP, amplified fragment length polymorphism; IMF, intramuscular fat.
Selected AFLP markers based on fragment frequency between high- and low-IMF contents in muscle tissue of pigs
| Marker | Primer combination | Fragment size (bp) | Frequency | p-value ( | |
|---|---|---|---|---|---|
|
| |||||
| High-IMF | Low-IMF | ||||
| AFLP1 | E-ACC/T-CCG | 223 | 0.25 | 0.45 | 0.0157 |
| AFLP2 | E-ACG/T-CTG | 71 | 0.30 | 0.48 | 0.0230 |
| AFLP3 | E-AGC/T-CCA | 167 | 0.15 | 0.43 | 0.0013 |
| AFLP4 | E- AGC/T-CTG | 136 | 0.48 | 0.28 | 0.0106 |
| AFLP5 | E- AGG/T-CAT | 84 | 0.18 | 0.35 | 0.0574 |
| AFLP6 | E- AGG/T-CCA | 188 | 0.03 | 0.20 | 0.0230 |
| AFLP7 | E-ATC/T-CGT | 79 | 0.05 | 0.28 | 0.0069 |
| AFLP8 | E-ATC/T-CGA | 176 | 0.50 | 0.18 | <0.0001 |
| AFLP9 | E-ACG/T-CTG | 152 | 0.15 | 0.35 | 0.0268 |
| AFLP10 | E-AGC/T-CTG | 171 | 0.05 | 0.23 | 0.0336 |
| AFLP11 | E-ATC/T-CGA | 198 | 0.15 | 0.45 | 0.0003 |
| AFLP12 | E-ACG/T-CTG | 145 | 0.10 | 0.28 | 0.0500 |
AFLP, amplified fragment length polymorphism; IMF, intramuscular fat.
Characterization of AFLP markers for fat deposition in muscle tissue of pigs
| Marker | Homology | GenBank accession no. | Chromosome location (Mb) | Base pair identity (%) | Mapped close to gene |
|---|---|---|---|---|---|
| AFLP1 | porcine DNA | NC_010459.4 | SSC17 (61.97) | 223/223 (100) | |
| AFLP2 | NC_010452.3 | SSC10 (71.22) | 71/71 (100) | ||
| AFLP3 | porcine DNA | NC_010449.4 | SSC7 (4.93) | 167/169 (99) | |
| AFLP7 | porcine DNA | NC_010451.3 | SSC9 (5.49) | 63/79 (90) | |
| AFLP10 | porcine DNA | NC_010450.3 | SSC8 (47.33) | 171/171 (100) |
AFLP, amplified fragment length polymorphism; ANKRD16, ankyrin repeat domain 16; CYP24A1, cytochrome P450 family 24 subfamily A member 1; DOK5, docking protein 5; GUCY1B3, guanylate cyclase 1 soluble beta 3; OR51V1, olfactory receptor family 51, subfamily V, member 1; RREB1, ras responsive element binding protein 1.
Genotype and allele frequencies of SNP markers in commercially crossbred pigs
| SNP | N | Genotype frequency | Allele frequency | |||
|---|---|---|---|---|---|---|
|
|
| |||||
| AA | AB | BB | A | B | ||
| SSC7 g.4937240C>G | 565 | 0.48 | 0.36 | 0.16 | 0.65 | 0.35 |
| SSC8 g.47338181G>A | 513 | 0.64 | 0.24 | 0.12 | 0.76 | 0.24 |
| SSC9 g.5496647_5496662insdel | 585 | 0.28 | 0.58 | 0.14 | 0.57 | 0.43 |
| SSC10 g.71225134G>A | 601 | 0.81 | 0.19 | 0.00 | 0.90 | 0.10 |
| SSC17 g.61976696G>T | 570 | 0.52 | 0.30 | 0.18 | 0.67 | 0.33 |
SNP, single nucleotide polymorphism.
Allele A represents major alleles of the SSC7 g.4937240C, SSC8 g.47338181A, SSC9 g.5496647_5496662del, SSC10 g.71225134A and SSC17 g.61976696G loci, respectively and allele B represents minor alleles of the SSC7 g.4937240G, SSC8 g.47338181G, SSC9 g.5496647_5496662ins, SSC10 g.71225134G and SSC17 g.61976696T loci, respectively.
Association of the SSC7 g.4937240C>G marker with IMF content and fatty acid composition traits in longissimus dorsi muscles in commercially crossbred pigs
| Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
|---|---|---|---|---|
|
| ||||
| CC (n = 180) | CG (n = 129) | GG (n = 63) | ||
| IMF | 2.628±0.170 | 2.364±0.177 | 2.212±0.258 | 0.0454 |
| C14:0 (Myristic) | 1.175±0.062 | 1.020±0.072 | 1.074±0.127 | 0.1241 |
| C16:0 (Palmitic) | 13.605±1.049 | 11.539±1.221 | 12.498±2.131 | 0.2944 |
| C18:0 (Stearic) | 12.366±0.897 | 10.827±1.044 | 10.999±1.823 | 0.3275 |
| C20:0 (Arachidic) | 0.303±0.067 | 0.278±0.078 | 0.187±0.136 | 0.7342 |
| SFA | 24.451±1.429 | 23.666±1.663 | 25.759±2.903 | 0.1074 |
| C16:1n-9 (Palmitoleic) | 3.957±0.320 | 3.534±0.373 | 4.433±0.651 | 0.4641 |
| C18:1n-9 (Oleic) | 32.675±1.924 | 32.657±2.239 | 31.358±3.909 | 0.9581 |
| C20:1n-9 (Eicosenoic) | 2.394±0.403 | 2.237±0.469 | 1.559±0.820 | 0.6521 |
| MUFA | 39.027±1.960 | 38.429±2.281 | 37.351±3.981 | 0.9093 |
| C18:2n-6 (Linoleic) | 24.373±1.592 | 26.243±1.852 | 27.504±3.234 | 0.1572 |
| C18:3n-6 (Linolenic) | 0.124±0.044 | 0.155±0.051 | 0.145±0.090 | 0.8318 |
| C20:2n-6 (Eicosadienoic) | 1.682±0.251 | 1.548±0.292 | 1.925±0.509 | 0.8332 |
| C20:3n-6 (Homolinolenic) | 0.142±0.050 | 0.274±0.058 | 0.185±0.102 | 0.1097 |
| C20:4n-6 (Arachidonic) | 0.166±0.119 | 0.224±0.139 | 0.232±0.143 | 0.3448 |
| PUFA | 26.489±1.610 | 28.447±1.873 | 29.429±2.270 | 0.1637 |
| ω3 FA | 1.311±0.263 | 1.539±0.306 | 1.473±0.535 | 0.2251 |
| ω6 FA | 24.993±1.651 | 27.031±1.921 | 27.004±1.353 | 0.1657 |
| ω9 FA | 36.633±1.944 | 36.192±2.261 | 37.792±3.948 | 0.9673 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Values in each row with different superscript letters are considered significantly different (p<0.05).
Association of the SSC17g.61976696G>T marker with IMF content and fatty acid composition traits in longissimus dorsi muscles in commercially crossbred pigs
| Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
|---|---|---|---|---|
|
| ||||
| GG (n = 175) | GT (n = 127) | TT (n = 52) | ||
| IMF | 2.104±0.128 | 2.594±0.195 | 2.172±0.335 | 0.0451 |
| C14:0 (Myristic) | 1.123±0.068 | 1.020±0.086 | 1.035±0.127 | 0.5482 |
| C16:0 (Palmitic) | 13.107±1.013 | 12.797±1.270 | 11.354±1.875 | 0.6481 |
| C18:0 (Stearic) | 11.768±0.812 | 12.327±1.019 | 10.808±1.054 | 0.6829 |
| C20:0 (Arachidic) | 0.301± 0.062 | 0.291±0.078 | 0.321±0.115 | 0.9702 |
| SFA | 26.301±1.373 | 26.437±1.722 | 23.519±2.542 | 0.2927 |
| C16:1n-9 (Palmitoleic) | 4.250±0.246 | 3.008±0.309 | 3.175±0.356 | 0.0153 |
| C18:1n-9 (Oleic) | 37.334±1.145 | 34.459±1.436 | 38.881±2.120 | 0.0967 |
| C20:1n-9 (Eicosenoic) | 2.322±0.372 | 1.726±0.467 | 1.846±0.489 | 0.0491 |
| MUFA | 43.906±1.278 | 39.194±1.603 | 38.904±1.565 | 0.0255 |
| C18:2n-6 (Linoleic) | 22.760±1.523 | 22.848±1.910 | 23.422±2.819 | 0.9722 |
| C18:3n-6 (Linolenic) | 0.145±0.039 | 0.107±0.049 | 0.210±0.073 | 0.4165 |
| C20:2n-6 (Eicosadienoic) | 1.596±0.224 | 1.403±0.281 | 1.242±0.415 | 0.6608 |
| C20:3n-6 (Homolinolenic) | 0.127±0.047 | 0.210±0.059 | 0.288±0.088 | 0.1730 |
| C20:4n-6 (Arachidonic) | 0.125±0.014 | 0.285±0.011 | 0.120±0.021 | 0.0432 |
| PUFA | 24.655±1.538 | 24.756±1.929 | 25.370±2.847 | 0.9684 |
| ω3 FA | 1.164±0.254 | 1.100±0.319 | 1.201±0.234 | 0.7431 |
| ω6 FA | 23.297±1.575 | 23.377±1.975 | 24.200±2.915 | 0.9510 |
| ω9 FA | 41.584±1.274 | 37.468±1.598 | 37.638±1.859 | 0.0472 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Values in each row with different superscript letters are considered significantly different (p<0.05).
Association of the SSC9 g.5496647_5496662insdel marker with IMF content and fatty acid composition traits in longissimus dorsi muscles in commercially crossbred pigs
| Traits (%) | Genotypes (Least squares mean±standard error) | p-value | ||
|---|---|---|---|---|
|
| ||||
| InsIns (n = 55) | InsDel (n = 230) | DelDel (n = 105) | ||
| IMF | 1.716±0.269 | 2.648±0.159 | 2.526±0.304 | 0.0155 |
| C14:0 (Myristic) | 1.150±0.243 | 1.096±0.073 | 1.025±0.103 | 0.7189 |
| C16:0 (Palmitic) | 13.729±3.503 | 13.287±1.054 | 11.538±1.487 | 0.4236 |
| C18:0 (Stearic) | 10.347±2.861 | 12.200±0.861 | 12.427±1.215 | 0.8258 |
| C20:0 (Arachidic) | 0.380±0.213 | 0.348±0.064 | 0.326±0.090 | 0.5580 |
| SFA | 25.307±4.809 | 26.933±1.448 | 25.316±2.042 | 0.6706 |
| C16:1n-9 (Palmitoleic) | 5.429±1.107 | 3.837±0.333 | 3.467±0.470 | 0.2907 |
| C18:1n-9 (Oleic) | 34.674±3.855 | 34.279±1.763 | 33.626±2.486 | 0.9379 |
| C20:1n-9 (Eicosenoic) | 1.646±1.075 | 2.424±0.384 | 1.829±0.541 | 0.3757 |
| MUFA | 39.224±4.899 | 40.541±1.776 | 38.924±2.505 | 0.7707 |
| C18:2n-6 (Linoleic) | 22.838±3.009 | 22.644±1.508 | 24.971±2.127 | 0.3214 |
| C18:3n-6 (Linolenic) | 0.158±0.138 | 0.113±0.041 | 0.68±0.058 | 0.5761 |
| C20:2n-6 (Eicosadienoic) | 1.267±0.804 | 1.687±0.242 | 1.513±0.341 | 0.7911 |
| C20:3n-6 (Homolinolenic) | 0.139±0.168 | 0.179±0.050 | 0.243±0.071 | 0.4402 |
| C20:4n-6 (Arachidonic) | 0.145±0.115 | 0.150±0.105 | 0.453±0.149 | 0.0282 |
| PUFA | 27.864±3.033 | 24.774±1.515 | 27.350±2.137 | 0.3266 |
| ω3 FA | 1.395±0.842 | 1.134±0.253 | 1.291±0.357 | 0.8691 |
| ω6 FA | 25.380±3.185 | 23.250±1.561 | 25.644±2.201 | 0.3371 |
| ω9 FA | 39.077±4.933 | 38.116±1.786 | 37.094±2.519 | 0.9032 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Values in each row with different superscript letters are considered significantly different (p<0.05).
Association of the SSC10 g.71225134G>A marker with IMF content and fatty acid composition traits in longissimus dorsi muscwles in commercially crossbred pigs
| Traits (%) | Genotypes (Least squares mean±standard error) | p-value | |
|---|---|---|---|
|
| |||
| AA (n =198) | AG (n = 57) | ||
| IMF | 2.287±0.121 | 2.397±0.282 | 0.7155 |
| C14:0 (Myristic) | 1.085±0.050 | 1.208±0.171 | 0.2614 |
| C16:0 (Palmitic) | 13.084±0.811 | 11.539±2.333 | 0.5121 |
| C18:0 (Stearic) | 11.384±0.646 | 13.692±1.858 | 0.2224 |
| C20:0 (Arachidic) | 0.263±0.048 | 0.323±0.140 | 0.6680 |
| SFA | 25.819±1.127 | 26.834±3.302 | 0.7210 |
| C16:1n-9 (Palmitoleic) | 3.860±0.243 | 5.323±0.699 | 0.0440 |
| C18:1n-9 (Oleic) | 34.576±0.919 | 36.785±2.366 | 0.3480 |
| C20:1n-9 (Eicosenoic) | 2.010±0.225 | 1.581±0.648 | 0.5126 |
| MUFA | 40.160±1.045 | 44.119±2.692 | 0.1436 |
| C18:2n-6 (Linoleic) | 25.510±1.213 | 22.110±3.491 | 0.3364 |
| C18:3n-6 (Linolenic) | 0.135±0.031 | 0.134±0.092 | 0.9963 |
| C20:2n-6 (Eicosadienoic) | 1.689±0.180 | 1.163±0.517 | 0.3170 |
| C20:3n-6 (Homolinolenic) | 0.181±0.038 | 0.089±0.110 | 0.4101 |
| C20:4n-6 (Arachidonic) | 0.115±0.089 | 0.034±0.257 | 0.7549 |
| PUFA | 27.632±1.227 | 23.532±3.529 | 0.2531 |
| ω3 FA | 1.294±0.177 | 0.907±0.603 | 0.5257 |
| ω6 FA | 26.155±1.257 | 23.634±3.617 | 0.3368 |
| ω9 FA | 35.992±1.291 | 44.322±3.655 | 0.0284 |
IMF, intramuscular fat content; SFA, saturated fatty acids (C14:0+C16:0+C18:0+C20:0); MUFA, monounsaturated fatty acids (C16:1n-9+C18:1n-9+C20:1n-9); PUFA, polyunsaturated fatty acids (C18:2n-6+C18:3n-6+C20:2n-6+C20:3n-6+C20:4n-6); ω3 fatty acids (C18:3n-3+C20:5n-3+C22:6n-3); ω6 fatty acids (C18:2n-6+C18:3n-6+C20:3n-6); ω9 fatty acids (C16:1n-9+C18:1n-9).
Values in each row with different superscript letters are considered significantly different (p<0.05).